Status: Not yet recruiting
Early Feasibility Study (EFS) of the Nyra Cardiac Leaflet Enhancer (CARLEN) System
Safety and performance evaluation of the CARLEN System in patients with functional mitral valve regurgitation.
Participants needed: 30
Trial details
Age: 21+Biological sex: AllType: InterventionalSponsor: Nyra Medical, Inc.Updated: Apr 13, 2026
Eligibility criteria
Age > 21 years at time of enrollment [+4]
Estimated life expectancy of less than 12 months [+15]